CervoMed Inc. Licenses Revenue (Deprecated 2018-01-31)
CervoMed Inc. (CRVO) reported Licenses Revenue (Deprecated 2018-01-31) of $71.67 thousand for the 3-month period ending 2013-03-31, per its 10-Q/A filed 2013-05-20.
Discontinued › Income Statement › Other Income
us-gaap:LicensesRevenue · last filed 2013-05-20
- CervoMed Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $71.67K, a 2.38% increase year-over-year.
- CervoMed Inc. licenses revenue (deprecated 2018-01-31) for the quarter ending 2012-03-31 was $70.00K.
- CervoMed Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2012 was $285.00K, a 35.67% decline from fiscal 2011.
- CervoMed Inc. licenses revenue (deprecated 2018-01-31) for fiscal 2011 was $443.00K.
| Period end | Licenses Revenue (Deprecated 2018-01-31) 3 month | Licenses Revenue (Deprecated 2018-01-31) 12 month |
|---|---|---|
| 2013-03-31 | $71.67K 10-Q/A · filed 2013-05-20 | |
| 2012-12-31 | $285.00K 10-K/A · filed 2013-04-24 | |
| 2012-03-31 | $70.00K 10-Q/A · filed 2013-05-20 | |
| 2011-12-31 | $443.00K 10-K/A · filed 2013-04-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |